A carregar...
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma
Although the introduction of bortezomib as a therapeutic strategy has improved the overall survival of multiple myeloma (MM) patients, 15–20% of high-risk patients do not respond to bortezomib over time or become resistant to treatment. Therefore, the development of new therapeutic strategies, such...
Na minha lista:
| Publicado no: | J Clin Med |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7073518/ https://ncbi.nlm.nih.gov/pubmed/32085480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9020552 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|